Microbot Medical Inc.
NASDAQ:MBOTMedical - Instruments & Supplies
-$0.06 today
- Market cap
- $65.73M
- Beta
- 1.04
- P/E (TTM)
- -8.6
- EPS (TTM)
- -$0.21
Volume 0.87M
Average 1.60M
MBOT Total Non-current Liabilities
All obligations due after more than one year.
Microbot Medical Inc.NASDAQ: MBOT
Total Non-current Liabilities · Q1 FY2026 · quarter ended Mar 2026
Total non-current liabilities rises 1095.8% from a year ago
Total non-current liabilities stood at $574K at the end of Q1 FY2026, up 1095.8% from a year earlier and up 0.9% from the prior quarter. Over 3 fiscal years it compounded at +47.0% a year.
Context
- Total non-current liabilities amounted to 0.7% of total assets at the end of Q1 FY2026, up 0.6 pp from a year earlier.
- Total non-current liabilities increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether total non-current liabilities keeps rising in the next quarterly balance sheet after a +1095.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Liabilities history
USD · from the balance sheet
- Latest · FY2025
- 569K USD
- Year-over-year change
- +1287.8%
- 4-year CAGR
- +9.1%
| Period | Period end | Total Non-current Liabilities | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 569K | +1287.8% |
| FY2024 | 2024-12-31 | 41K | +2.5% |
| FY2023 | 2023-12-31 | 40K | -77.7% |
| FY2022 | 2022-12-31 | 179K | -55.5% |
| FY2021 | 2021-12-31 | 402K | — |
Total Non-current Liabilities vs competitors
How MBOT compares with its peers on the latest reported figures
- Peers report in different currencies, so total non-current liabilities is compared through growth and share of total assets rather than absolute size.
- Its year-over-year change of +1095.8% is the highest of 10, against a peer median of -2.3%.
- Total non-current liabilities amounts to 0.7% of total assets for MBOT, versus a peer median of 9.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $33.74M USD | +72.8% | -3.1% | 155.7% | |
| Mar 2026 | $20.8M USD | -2.3% | +18.7% | 9.9% | |
| Mar 2026 | $20.01M USD | +829.3% | +36.4% | 7.4% | |
| Mar 2026 | $16.49M USD | -6.4% | — | 38.9% | |
| Mar 2026 | $11.61M USD | -11.2% | -9.2% | 5.1% | |
| Mar 2026 | $8.04M USD | -84.3% | +54.1% | 15.6% | |
| Mar 2026 | CA$1.76M CAD | +985.6% | +53.6% | 11.6% | |
| Mar 2026 | $574K USD | +1095.8% | +47.0% | 0.7% | |
| Mar 2026 | $122.37K USD | +48.1% | — | 0.2% | |
| Mar 2026 | CA$76.81K CAD | -34.0% | +74.0% | 0.2% | |
| Peer median (excluding MBOT) | — | -2.3% | +36.4% | 9.9% | |
Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Microbot Medical Inc.
NASDAQ:MBOT
Intrinsic Alpha fair value
Locked
Current Price
$0.98
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.